Possible artemisinin-based combination therapy-resistant malaria in Nigeria: a report of three cases

Possible artemisinin-based combination therapy-resistant malaria in Nigeria: a report of three cases

Artemisinin-based combination therapy-resistant malaria is rare in Sub-Saharan Africa. The World Health Organization identifies monitoring and surveillance using day-3 parasitaemia post-treatment as the standard test for identifying suspected artemisinin resistance. We report three cases of early tr...

Full description

Bibliographic Details
Main Authors:	Nnennaya Anthony Ajayi, Kingsley Nnanna Ukwaja
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Medicina Tropical (SBMT) 2013-07-01
Series:	Revista da Sociedade Brasileira de Medicina Tropical
Subjects:	Malaria Artemisinin-based combination therapy Artemether-lumefantrine Early treatment failure Resistance Nigeria
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822013000400525&lng=en&tlng=en

Similar Items

Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Mali: a systematic review and meta-analysis
by: Fatoumata O. Maiga, et al.
Published: (2021-08-01)

Cost-effectiveness of artemisinin–naphthoquine versus artemether–lumefantrine for the treatment of uncomplicated malaria in Papua New Guinean children
by: Brioni R. Moore, et al.
Published: (2017-10-01)

Prospective evaluation of artemether-lumefantrine for the treatment of non-falciparum and mixed-species malaria in Gabon
by: Mombo-Ngoma Ghyslain, et al.
Published: (2012-07-01)

Efficacy of artemether-lumefantrine, the nationally-recommended artemisinin combination for the treatment of uncomplicated falciparum malaria, in southern Laos
by: Mayxay Mayfong, et al.
Published: (2012-06-01)

Asymptomatic recrudescence after artemether–lumefantrine treatment for uncomplicated falciparum malaria: a systematic review and meta-analysis
by: Rida Mumtaz, et al.
Published: (2020-12-01)

A systematic review of the safety and efficacy of artemether-lumefantrine against uncomplicated <it>Plasmodium falciparum</it> malaria during pregnancy
by: Manyando Christine, et al.
Published: (2012-05-01)

Adherence to treatment with artemether–lumefantrine or amodiaquine–artesunate for uncomplicated malaria in children in Sierra Leone: a randomized trial
by: Kristin Banek, et al.
Published: (2018-06-01)

Surveillance of genetic markers associated with Plasmodium falciparum resistance to artemisinin-based combination therapy in Pakistan, 2018–2019
by: Abdul Qader Khan, et al.
Published: (2020-06-01)

Watching the availability and use of rapid diagnostic tests (RDTs) and artemisinin-based combination therapy (ACT)
by: Richard W. Steketee, et al.
Published: (2017-04-01)

The use of paediatric artemisinin combinations in sub-Saharan Africa: a snapshot questionnaire survey of health care personnel
by: Agnandji Selidji T, et al.
Published: (2011-12-01)

Effectiveness and safety of 3 and 5 day courses of artemether–lumefantrine for the treatment of uncomplicated falciparum malaria in an area of emerging artemisinin resistance in Myanmar
by: Kyaw Myo Tun, et al.
Published: (2018-07-01)

Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria and prevalence of Pfk13 and Pfmdr1 polymorphisms after a decade of using artemisinin-based combination therapy in mainland Tanzania
by: Deus S. Ishengoma, et al.
Published: (2019-03-01)

Malaria healthcare policy change in Kenya: Implications on sales and marketing of antimalarials
by: Peter K. Ngure , Lorraine Nyaoke & David Minja
Published: (2012-03-01)

Post-artemisinin delayed hemolysis after oral therapy for P. falciparum infection
by: Christian C. Conlon, et al.
Published: (2020-01-01)

Efficacy of artemether .. lumefantrine and artesunate-amodiaquine for treating uncomplicated falciparum malaria in children
by: Tri Faranita, et al.
Published: (2012-10-01)

Data on pilot assessment of efficacy of artemether lumefantrine when co-administered with ciprofloxacin in malaria-typhoid co-infected patients
by: Segun Solomon Ogundapo, et al.
Published: (2021-02-01)

Artemether-lumefantrine to treat malaria in pregnancy is associated with reduced placental haemozoin deposition compared to quinine in a randomized controlled trial
by: Muehlenbachs Atis, et al.
Published: (2012-05-01)

Therapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in four malaria endemic states of India
by: Sri Krishna, et al.
Published: (2021-05-01)

High adherence level to artemisinin-based combination therapies in rural settlement 11 years after their introduction in the health system, Nanoro, Burkina Faso
by: Rouamba T, et al.
Published: (2019-02-01)

Efficacy of artemether-lumefantrine as a treatment for uncomplicated <it>Plasmodium vivax</it> malaria in eastern Sudan
by: Abdallah Tajeldin M, et al.
Published: (2012-12-01)

Therapeutic efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Chewaka District, Ethiopia
by: Abdulhakim Abamecha, et al.
Published: (2020-07-01)

Artemether-lumefantrine treatment failure of uncomplicated Plasmodium falciparum malaria in travellers coming from Angola and Mozambique
by: André Silva-Pinto, et al.
Published: (2021-09-01)

Efficacy of six-dose regimen of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria, three years after its introduction into Ethiopia
by: Kefyalew T., et al.
Published: (2009-06-01)

Formulation, process development and evaluation of artemether and lumefantrine soft gelatin capsule
by: A Patel, et al.
Published: (2012-01-01)

Open-label trial with artemether-lumefantrine against uncomplicated <it>Plasmodium falciparum</it> malaria three years after its broad introduction in Jimma Zone, Ethiopia
by: Eshetu Teferi, et al.
Published: (2012-07-01)

Prevalence and factors associated with carriage of Pfmdr1 polymorphisms among pregnant women receiving intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP) and artemether-lumefantrine for malaria treatment in Burkina Faso
by: Hamtandi Magloire Natama, et al.
Published: (2020-11-01)

High therapeutic efficacy of artemether–lumefantrine and dihydroartemisinin–piperaquine for the treatment of uncomplicated falciparum malaria in Somalia
by: Marian Warsame, et al.
Published: (2019-07-01)

Efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria among children in Africa: a systematic review and meta-analysis of randomized control trials
by: Dawit Getachew Assefa, et al.
Published: (2021-08-01)

Efficacy and safety of dihydroartemisinin–piperaquine versus artemether–lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Ugandan children: a systematic review and meta-analysis of randomized control trials
by: Dawit Getachew Assefa, et al.
Published: (2021-04-01)

Efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Nepal
by: Prakash Ghimire, et al.
Published: (2018-08-01)

Optimal timing of primaquine to reduce Plasmodium falciparum gametocyte carriage when co-administered with artemether–lumefantrine
by: Seif Shekalaghe, et al.
Published: (2020-01-01)

Safety monitoring experience of single-low dose primaquine co-administered with artemether–lumefantrine among providers and patients in routine healthcare practice: a qualitative study in Eastern Tanzania
by: Dominic Mosha, et al.
Published: (2021-10-01)

A randomized clinical trial comparing safety, clinical and parasitological response to artemether-lumefantrine and chlorproguanil-dapsone in treatment of uncomplicated malaria in pregnancy in Mulago
by: Daniel Kabonge Kaye,1 Ruth Nshemerirwe,1 Twaha Serunjogi Mutyaba,1 Grace Ndeezi.2
Published: (2008-04-01)

Therapeutic efficacy of artemether–lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria from three highly malarious states in India
by: Praveen K. Bharti, et al.
Published: (2016-10-01)

Pyronaridine-artesunate granules versus artemether-lumefantrine crushed tablets in children with <it>Plasmodium falciparum</it> malaria: a randomized controlled trial
by: Kayentao Kassoum, et al.
Published: (2012-10-01)

Therapeutic efficacy of artemether-lumefantrine combination in the treatment of uncomplicated malaria among children under five years of age in three ecological zones in Ghana
by: Abuaku Benjamin, et al.
Published: (2012-11-01)

Monitoring of efficacy, tolerability and safety of artemether–lumefantrine and artesunate–amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Lambaréné, Gabon: an open-label clinical trial
by: Bayode R. Adegbite, et al.
Published: (2019-12-01)

The use and preference of artemether as a first-choice treatment for malaria: results from a cross-sectional survey in the Bata district, Equatorial Guinea
by: Maria Romay-Barja, et al.
Published: (2018-03-01)

Efficacy of fixed-dose combination artesunate-amodiaquine <it>versus</it> artemether-lumefantrine for uncomplicated childhood <it>Plasmodium falciparum</it> malaria in Democratic Republic of Congo: a randomized non-inferiority trial
by: Espié Emmanuelle, et al.
Published: (2012-05-01)

Clinical illness and outcomes in Nigerian children with persistent early-appearing anaemia following initiation of artemisinin-based combination treatments of uncomplicated falciparum malaria
by: Akano Kazeem, et al.
Published: (2019-01-01)

Cannot write session to /tmp/vufind_sessions/sess_cg45oh6hrnhia2erjl0k14eon1